title: [How should pharmacodynamic tests for respiratory tract obstruction be evaluated?].
abstract: The factors that could influence the results of pharmacodynamic testing with beta 2 agonists in lung function diagnostics are discussed. These are: hypersecretion of the mucus, acute respiratory infection, tachyphylaxis of the adrenoceptors, therapy in the past 48 hours, patient's cooperation, and ambient or environmental pollution. The correct application, by inhalation, of selective sympathomimetics is described and differences between the basic values of lung function parameters and those following the salbutamol test are discussed.
authors.affiliation: Klinika za plućne bolesti Medicinskog fakulteta Sveucilista u Zagrebu.
authors.forename: S
authors.initials: S
authors.lastname: Popović-Grle
authors.forename: F
authors.initials: F
authors.lastname: Pavicić
authors.forename: V
authors.initials: V
authors.lastname: Bićanić
authors.forename: Z
authors.initials: Z
authors.lastname: Radosević
mesh_terms: D001249:Asthma / Q000175:diagnosis*; D001993:Bronchodilator Agents; D006801:Humans; D012129:Respiratory Function Tests
chemical_list: D001993:Bronchodilator Agents
vernacular_title: Kako procijeniti farmakodinamski test pri opstrukciji disnih putova?